Literature DB >> 26183928

Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.

Shuguang Leng1, Guodong Wu1, Leonard B Collins2, Cynthia L Thomas1, Carmen S Tellez1, Andrew R Jauregui3, Maria A Picchi1, Xiequn Zhang1, Daniel E Juri1, Dhimant Desai4, Shantu G Amin4, Richard E Crowell5, Christine A Stidley5, Yushi Liu1, James A Swenberg2, Yong Lin1, Marc G Wathelet3, Frank D Gilliland6, Steven A Belinsky7.   

Abstract

O(6)-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that protects cells from carcinogenic effects of alkylating agents; however, MGMT is silenced by promoter hypermethylation during carcinogenesis. A single-nucleotide polymorphism (SNP) in an enhancer in the MGMT promoter was previously identified to be highly significantly associated with risk for MGMT methylation in lung cancer and sputum from smokers. To further genetic investigations, a genome-wide association and replication study was conducted in two smoker cohorts to identify novel loci for MGMT methylation in sputum that were independent of the MGMT enhancer polymorphism. Two novel trans-acting loci (15q15.2 and 17q24.3) that were identified acted together with the enhancer SNP to empower risk prediction for MGMT methylation. We found that the predisposition to MGMT methylation arising from the 15q15.2 locus involved regulation of the ubiquitin protein ligase E3 component UBR1. UBR1 attenuation reduced turnover of MGMT protein and increased repair of O6-methylguanine in nitrosomethylurea-treated human bronchial epithelial cells, while also reducing MGMT promoter activity and abolishing MGMT induction. Overall, our results substantiate reduced gene transcription as a major mechanism for predisposition to MGMT methylation in the lungs of smokers, and support the importance of UBR1 in regulating MGMT homeostasis and DNA repair of alkylated DNA adducts in cells. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26183928      PMCID: PMC4526392          DOI: 10.1158/0008-5472.CAN-15-0243

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Use of antibodies to human O6-alkylguanine-DNA alkyltransferase to study the content of this protein in cells treated with O6-benzylguanine or N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  A E Pegg; L Wiest; C Mummert; L Stine; R C Moschel; M E Dolan
Journal:  Carcinogenesis       Date:  1991-09       Impact factor: 4.944

2.  Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP.

Authors:  Lasse Sommer Kristensen; Helene Myrtue Nielsen; Henrik Hager; Lise Lotte Hansen
Journal:  Lung Cancer       Date:  2010-06-02       Impact factor: 5.705

3.  The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.

Authors:  Shuguang Leng; Amanda M Bernauer; Chibo Hong; Kieu C Do; Christin M Yingling; Kristina G Flores; Mathewos Tessema; Carmen S Tellez; Randall P Willink; Elizabeth A Burki; Maria A Picchi; Christine A Stidley; Michael D Prados; Joseph F Costello; Frank D Gilliland; Richard E Crowell; Steven A Belinsky
Journal:  Clin Cancer Res       Date:  2011-02-25       Impact factor: 12.531

Review 4.  Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools.

Authors:  Anthony E Pegg
Journal:  Chem Res Toxicol       Date:  2011-04-28       Impact factor: 3.739

5.  Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker.

Authors:  M Catherine Pietanza; Kyuichi Kadota; Kety Huberman; Camelia S Sima; John J Fiore; Dyana K Sumner; William D Travis; Adriana Heguy; Michelle S Ginsberg; Andrei I Holodny; Timothy A Chan; Naiyer A Rizvi; Christopher G Azzoli; Gregory J Riely; Mark G Kris; Lee M Krug
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531

6.  A method for simultaneous identification of human active and active-site alkylated O6-methylguanine-DNA methyltransferase and its possible application for monitoring human exposure to alkylating carcinogens.

Authors:  T C Ayi; H K Oh; T K Lee; B F Li
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

7.  FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs.

Authors:  Simon G Coetzee; Suhn K Rhie; Benjamin P Berman; Gerhard A Coetzee; Houtan Noushmehr
Journal:  Nucleic Acids Res       Date:  2012-06-08       Impact factor: 16.971

8.  Comparative anatomy of chromosomal domains with imprinted and non-imprinted allele-specific DNA methylation.

Authors:  Anupam Paliwal; Alexis M Temkin; Kristi Kerkel; Alexander Yale; Iveta Yotova; Natalia Drost; Simon Lax; Chia-Ling Nhan-Chang; Charles Powell; Alain Borczuk; Abraham Aviv; Ronald Wapner; Xiaowei Chen; Peter L Nagy; Nicholas Schork; Catherine Do; Ali Torkamani; Benjamin Tycko
Journal:  PLoS Genet       Date:  2013-08-29       Impact factor: 5.917

9.  The N-end rule pathway is mediated by a complex of the RING-type Ubr1 and HECT-type Ufd4 ubiquitin ligases.

Authors:  Cheol-Sang Hwang; Anna Shemorry; Daniel Auerbach; Alexander Varshavsky
Journal:  Nat Cell Biol       Date:  2010-11-14       Impact factor: 28.824

10.  Population-specificity of human DNA methylation.

Authors:  Hunter B Fraser; Lucia L Lam; Sarah M Neumann; Michael S Kobor
Journal:  Genome Biol       Date:  2012-02-09       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.